Transcript Anestezia

“Nothing in life is to be feared.
It is only to be understood.”
Marie Curie (`868-1934)
General anesthesia
Regional anesthesia
Monitored anesthesia care
General
anesthesia
“Before him surgery was agony.”
Epitaph on a monument honoring W. Morton
General anesthesia
The goals of general anesthesia:
- Mandatory: -amnesia/sedation/hypnosis
-analgesia
-maintenance of homeostasis
- Optionally: -muscle relaxation
General anesthesia indications

Indications based on the surgical procedure:
-surgical procedures requiring analgesia and
muscle relaxation, that cannot be performed
using regional anesthesia techniques: upper
abdominal surgery, thoracic surgery, head and
neck surgery, shoulder surgery etc.
-surgical procedures that significally interfere
with vital functions: neurosurgery, thoracic
surgery, cardiac surgery, surgery of the aorta etc.
General anesthesia indications

Indications based on the patient condition:
-different pathologies or ongoing treatments that
make
the
regional
anesthesia
tachniques
contraindicated: the patients with coagulation
disorders, anticoagulant treatments, infections or other
lesions in the area where a regional anesthesia
procedure would be performed;
-systemic diseases with definite functional
limitations: the patient with respiratory insufficency,
shock, coma, major hydroelectrolytic or acido-basic
imbalance.
Drugs used for general anesthesia
Hypnosis
Analgesia
Muscle relaxation
Maintenance of homeostasis
can all be achieved by administering
one or more drugs
Drugs used for general anesthesia
• Inhalatory anesthetics:
-gaseous form
nitrous oxide
-volatile liquids
halothane, isoflurane, sevoflurane si desflurane

The advantage of entering and leaving the body by
ventilation with minimal metabolization.
 They result in sedation, analgesia and light muscle
relaxation.
The potency of an inhalatory anesthetic
MAC (minimal alveolar concentration)
= the alveolar concentration of the anesthetic that
abolishes the movements caused by the skin incision in
50% of the patients
Each inhalatory anesthetic has its own specific MAC.
Modern anesthesia - new types of MAC:
•
•
•
MAC intubation ( MAC that facilitates the intubation in 50% of the patients);
MAC bar (MAC that abolishes the hemodynamic response in 50% of the
patients);
MAC awake (MAC at which awakening occurs in 50% of the patients).
Inhalant
anesthetic
Class
Concentration Advantages/disadvantages Side effects
in balanced
anesthesia
Nitrous
oxide
Gaseous
40-66%
Light analgesia
Accumulation in airway
spaces
Risk of
hypoxemia
Euforia
Halothane
Volatile
1,5-2%
Bronchodilatation
Slow dynamics
Cardiovascular
depression
Isoflurane
Volatile
1,5-2%
Bronchodilatation
Medium dynamics
Vasodilatation
Sevoflurane
Volatile
2-3%
Bronchodilatation
Fast dynamics
Cardio-vascular stability
Compound A
Desflurane
Volatile
6-8%
Airway irritant
Special vapporiser
Sympathetic
stimulation
 Intravenous
anesthetics:
Short acting:
Barbiturates
→ metohexital
thiopental, tiamital
Imidazolic compounds → etomidate
Alkylphenols
→ propofol
Steroids
→ eltanolone
Long acting:
Ketamine
Benzodiazepines
→ diazepam, midazolam
THIOPENTAL:
-very rapid induction; maximal effect in 40 s;
-superficial anesthetic sleep;
-NO an analgesic effect;
-weak muscle relaxation.
Administration: slow i.v.
Side effects: risk of respiratory and circulatory
depression
PROPOFOL
-very liposoluble fatty acid;
-hepatic metabolisation in great extent → short effect;
Pharmacodynamic action:
-pharmacologic effects similar with those of
Thiopental;
-less residual effects.
KETAMINE
Pharmacodynamic action:
Dissociative anesthetic:
- dissociation from the environment
- superficial sleep
- strong analgesia
Advantages:-No respiratory depressant effect;
-hemodynamic stability by the release of
catecholamines
-bronchodilatatory effect
Hypnotic
Class
Induction
dose
Single dose
duration of
action
Side effects
Thiopental
Short acting
barbituric
2-4 mg/kg
5-10 min
Arterial
hypotension,
respiratory
depression,
tachycardia,
decreases the
cardiac output
Propofol
Alkylphenol
1-2 mg/kg
5-10 min
Arterial
hypotension,
respiratory
depression,
tachycardia
Etomidat
Imidazolic
compound
0,3 mg/kg
5-10 min
Adrenal glad
inhibition
Diazepam
Benzodiazepines
0,3 mg/kg
10-60 min
Interindividual
response
variability
Midazolam
Benzodiazepines
0,2-0,3
mg/kg
5-15 min
Respiratory
depression
 Analgetics:
Opioids:
-the class of analgesics with the broadest intraanesthetic utilisation;
-profound dose-dependant analgesia;
-in spite of their quasi-constant use during general
anesthesia, the opioids are not anesthetics because
the loss of consciousness is not a regular effect
-they regularly result in respiratory dosedependent depression. Cardiovascular depression is a
variable effect.
Opioids
Class
Medium
dose
Single dose
duration of
action
Side effects
Morphine
μ Agonist
0,2 mg/kg
30-60 min
Respiratory depression,
sedation. hTA,
bradycardia
Pethidine
μ/Δ
Agonist
1 mg/kg
20-30 min
Sedation,
nausea/vomiting, HTA,
tachycardia
Fentanil
μ Agonist
5-15 μg/kg
20 min
Respiratory depression
Sufentanil
μ Agonist
0,3-1
μg/kg
Respiratory depression
Alfentanil
μ Agonist
5-50 μg/kg
Respiratory depression
Remifenta
nil
μ Agonist
0,5-1
μg/kg
1-3 min
Respiratory depression
Buprenorp
hine
Agonist/
antagonist
0,3 mg
3-4 ore
Ceilling effect
 Muscle
relaxants:
-substances that act at the neuromuscular junction
level and prevent the transmission of the physiologic
stimulus for the muscular contraction;
-NO action on the CNS, NO loss of consciousness,
NO analgesia;
-utilized for the facilitation of the airway
instrumentation, of mechanical ventilation and of the
surgical intervention;
-results in alveolar hypoventilation or apnea by the
action on the respiratory muscles;
-minimal cardio-vascular effects.
Muscular
relaxant
Class
Intubation
dose
Single dose
duration of
action
Particular
instructions
Succinylcholi
ne
D
1-1,5 mg/kg
10-15 min
Full stomach
Pancuronium
ND
0,1 mg/kg
30-40 min
Bradycardia
Vecuronium
ND
0,08 mg/kg
20-30 min
Cardiac
affections
Atracurium
ND
0,5 mg/kg
20 min
Kidney failure
Cisatracurium
ND
0,2 mg/kg
20 min
Kidney failure
Mivacurium
ND
0,2 mg/kg
10-15 min
Short
interventions
Rocuronium
ND
0,6-0,9 mg/kg
30-60 min
Full stomach
 Anesthesia
apparatus
Anesthesia Apparatus

Components:
-connection with the sources
of medical fluids
-flowmeters
-vaporizers
-anesthetic circuit
-CO2 scavenger system
-balloon ventilation system
-overpressure valve
-mechanical ventilation module
-emergency oxygen delivery circuit
-ventilation parameters setting module;
-ventilation parameters and inhalation anesthetics
monitoring module;
-alarm module;
-vacuum system (sucction).
 Intraanesthesic
monitoring
Intraanesthesic monitoring
 Standard I:
-the presence in the room of an anesthesiologist or
a qualified staff member throughout the duration of
the anesthesia.
 Standard II:
-oxygenation: inspiratory oxygen concentration
(FiO2), pulsoxymetry (SpO2);
-ventilation: clinical evaluation, auscultation,
capnography;
-circulation: electrocardioscopy (continuous),
noninvasive arterial blood pressure and pulse
measurement;
-body temperature.
Monitoring
Respiratory
Airway pressure, tidal volume, minute ventilation, respiratory rate,
O2/CO2 inspiratory concentration, concentration of volatile
anesthetic agent, pulsoxymetry
Cardiovascular
Non-invasive arterial pressure, multiple leads ECG, computerized
analysis of ST segment, central venous pressure, pulmonary
artery pressure (systolic, medium, diastolic, wedge) cardiac
output, extra-vascular pulmonary water, peripheral vascular
resistance, ScvO2, SvO2.
Hypnosis
BIS (bispectral index)
Muscle relaxation
Peripheral nerve stimulator
Renal
Diuresis
Temperature
Central, peripheral
Acid - base
equilibrium
Blood gas analysis
Electrolytes
Na, K, Cl, Ca
Haematological
analysis, coagulation
studies
Platelets, aPTT, INR
Oxygen
transportation
Hb, Ht, cardiac output, SaO2, PaO2
Metabolic
Glucose
 Preanesthetic
visit

Preanesthetic exam:
-psychological preparation of the patient;
-clinical and laboratory evaluation of the patient;
-asignement to an anesthetic risk group (ASA scale)
-choosing the anesthetic technique and obtaining
informed consent;
-set up of an anesthetic plan.
Risk I
Patient without systemic diseases
Risk II
Patient with systemic diseases without functional limitation
Risk III
Patient with systemic diseases with functional limitation
Risk IV
Patient with uncompensated systemic disease
Risk V
Dying patient
Risk VI
Brain dead patient, organ donor
E
Emergency procedure
the
Optimizing the patient status:
-the correction of dysfunctions and diseases in
the preoperative period.
 Premedication :
-reduced anxiety and reduced need for intraoperative anesthetics;
-decreasing certain risks (parasympathetic
reflexes, the risk of aspiration);
-the facilitation of postoperative analgesia.

Phases of general anesthesia



Induction phase:
-the period of transition from the state of conscious to the
state of general anesthesia;
-CNS depression, ventilatory, cardiovascular depression,
muscle relaxation;
-securing the airway.
Maintenace phase:
-providing the adequate depth of anesthesia by
administering anesthetics, analgesics and muscle relaxant
agents.
Emergency phase:
-the interruption of the administration of all volatile or
intravenous anesthetic agents;
-the antagonisation of the muscle relaxant drug.
General anesthesia techniques
Balanced anesthesia;
 Intravenous anesthesia;
 Volatile anesthesia;
 Combined techniques of general and regional
anesthesia:
-general anesthesia + epidural anesthesia.

General anesthesia complications
Respiratory
Hypoxemia, hypercapnia laryngeal spasm, bronchospasm,
aspiration, ARDS, atelectasis
Cardio-vascular
High/low blood pressure, tachy/bradycardia, myocardial
ischemia, arrhythmia , hypovolemia, low cardiac output
CNS
Convulsions, shivers, post anoxic encephalopathy, paresis
by compression or elongation of peripheral nerves
Digestive
Vomiting or regurgitation, hiccup
Renal
Oligo/anuria, urinary retention, pre - renal failure
Metabolice
Hyper/hypoglycemia, malignant hyperthermia
Hidro-electrolitics
Extracellular space expansion (interstitial oedema),
hypo/hyperkalemia, hypocalcemia
Acid-base
Hypercloremic metabolic acidosis, lactacidemic
Coagulation
Thrombocytopenia, dilutional coagulopathy, deep venous
thrombosis
Allergical
Cutaneous eruptions, Quincke oedema, bronchospasm,
anaphylactic shock
Cutaneous
Decubitus injury, accidental burns
Regional anesthesia

Subarachnoid (spinal)
 Epidural
 Sequential
 Caudal
Regional anesthesia
Indications:
-the area can be anesthetised using regional blocks;
-the surgical procedure does not affect the vital
functions;
-patient's informed consent;
 Contraindications:
-patient's refusal;
-active coagulation disorders or anticoagulant
treatment;
-infections or haematoma at injection site;
-neurological deficit and lack of cooperation.

Spinal Anethesia:
analgesia
muscle relaxation
sympathetic blockade
-sympathetic blockade: hypotension, bradycardia,
urinary retention;
-hypovolemia is an absolute contraindication of spinal
anesthesia;
-epidural analgesia is the standard procedure for
peripartum analgesia;
-complications: systemic (high spred of anesthetictotal spinal anesthesia or systemic toxicity), headache.
Local anesthetics
Amides
Lidocain
Esters
Prilocain
Procain
Mepivacain
Etidocain
Tetracain
Bupivacain
Ropivacain
Benzocain
Clinical use of local anesthetics
Central regional anesthesia/analgesia
Regional intravenous anesthesia
Peripheral nerve block or plexus
Infiltration anesthesia
Local anesthesia
Blocking of thehemodynamic response during
tracheal intubation
in regional anesthesia we frequently use the combination between a local anesthetic and
adrenaline, an opioid or clonidine, increasing the duration and quality of the block
During regional anesthesia – mandatory equipments:
 Anesthesia delivery system
 Equipments and materials for airway management
 Oxygen source
 Monitoring:
ventilation,
pressure, EKG.
oxygenation,
circulation,
blood
 Spinal
anesthesia (sub-arachnoid block)

Epidural anesthesia
 Sequential
(combined) anesthesia
spinal / epidural
 Caudal
anesthesia
 Plexus
anesthesia or peripheral nerves
blockade
 Single-shot
 Catheter
 Local
anesthesia
contact
topical - skin, mucous membrane application
 tissue infiltration
Monitored anesthesia care
Monitored anesthesia care
- intravenous administration of anxiolytic, sedative,
analgesic and amnesic drugs either isolated or
supplementing a regional anesthesia procedure;
- indicated in: painful diagnostic or therapeutic
procedures or supplementing a inappropiate regional
block;
- the CPR equipments must be close-by at all times;
- complications: respiratory depression with
hypoventilation and loss of airway protection.